NASDAQ •
Healthcare •
Biotechnology •
Quote as of 05/04/2026 16:00
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization119.12 mln
Float10.86 mln
Earnings Date05/20/2026
Piotroski F-Score
3
/ 9
Below average
1-Year Forecast
16.90
Transformational upside
Relative Strength
18
/ 100
Significantly lagging
Debt / Equity
0.00
Debt-free
ROE
-62.33
Deeply negative
Dividend Yield
0.00%
No dividend
Business Description
Aardvark Therapeutics is a San Diego-based drug development company founded in 2017. It works on creating oral medicines that trigger the body's natural processes to help treat conditions like obesity and diabetes.
